Vincenza Conteduca, Alessandra Mosca, Nicole Brighi, Ugo de Giorgi, Pasquale Rescigno. Cells 2021
Times Cited: 9
Times Cited: 9
Times Cited
Times Co-cited
Similarity
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez, A Jayaram, S Salvi, D Castellano, A Romanel, C Lolli,[...]. Ann Oncol 2017
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez, A Jayaram, S Salvi, D Castellano, A Romanel, C Lolli,[...]. Ann Oncol 2017
55
Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
44
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Howard I Scher, Michael J Morris, Walter M Stadler, Celestia Higano, Ethan Basch, Karim Fizazi, Emmanuel S Antonarakis, Tomasz M Beer, Michael A Carducci, Kim N Chi,[...]. J Clin Oncol 2016
Howard I Scher, Michael J Morris, Walter M Stadler, Celestia Higano, Ethan Basch, Karim Fizazi, Emmanuel S Antonarakis, Tomasz M Beer, Michael A Carducci, Kim N Chi,[...]. J Clin Oncol 2016
44
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer.
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, Daniel Wetterskog, Samanta Salvi, Giorgia Gurioli, Emanuela Scarpi, Elena Castro, Mercedes Marin-Aguilera, Cristian Lolli,[...]. Eur Urol 2019
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, Daniel Wetterskog, Samanta Salvi, Giorgia Gurioli, Emanuela Scarpi, Elena Castro, Mercedes Marin-Aguilera, Cristian Lolli,[...]. Eur Urol 2019
33
Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi, Daniel Wetterskog, Samanta Salvi, Dino Amadori, Zafeiris Zafeiriou, Pasquale Rescigno,[...]. Sci Transl Med 2015
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi, Daniel Wetterskog, Samanta Salvi, Dino Amadori, Zafeiris Zafeiriou, Pasquale Rescigno,[...]. Sci Transl Med 2015
33
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
Alexander W Wyatt, Arun A Azad, Stanislav V Volik, Matti Annala, Kevin Beja, Brian McConeghy, Anne Haegert, Evan W Warner, Fan Mo, Sonal Brahmbhatt,[...]. JAMA Oncol 2016
Alexander W Wyatt, Arun A Azad, Stanislav V Volik, Matti Annala, Kevin Beja, Brian McConeghy, Anne Haegert, Evan W Warner, Fan Mo, Sonal Brahmbhatt,[...]. JAMA Oncol 2016
33
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, Kevin Beja, Felix Feng, Jack Youngren, Adam Foye, Paul Lloyd, Matti Nykter, Tomasz M Beer,[...]. J Natl Cancer Inst 2017
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, Kevin Beja, Felix Feng, Jack Youngren, Adam Foye, Paul Lloyd, Matti Nykter, Tomasz M Beer,[...]. J Natl Cancer Inst 2017
33
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.
Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, Yu Miyazaki, Yuki Makino, Kosuke Okasho, Xin Li, Noriaki Utsunomiya, Takayuki Goto, Takashi Kobayashi,[...]. Sci Rep 2019
Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, Yu Miyazaki, Yuki Makino, Kosuke Okasho, Xin Li, Noriaki Utsunomiya, Takayuki Goto, Takashi Kobayashi,[...]. Sci Rep 2019
22
Chemistry and structural biology of androgen receptor.
Wenqing Gao, Casey E Bohl, James T Dalton. Chem Rev 2005
Wenqing Gao, Casey E Bohl, James T Dalton. Chem Rev 2005
22
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians.
Axel S Merseburger, Nick Waldron, Maria J Ribal, Axel Heidenreich, Sven Perner, Karim Fizazi, Cora N Sternberg, Joaquin Mateo, Manfred P Wirth, Elena Castro,[...]. Eur Urol 2021
Axel S Merseburger, Nick Waldron, Maria J Ribal, Axel Heidenreich, Sven Perner, Karim Fizazi, Cora N Sternberg, Joaquin Mateo, Manfred P Wirth, Elena Castro,[...]. Eur Urol 2021
22
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
Adam Sharp, Ilsa Coleman, Wei Yuan, Cynthia Sprenger, David Dolling, Daniel Nava Rodrigues, Joshua W Russo, Ines Figueiredo, Claudia Bertan, George Seed,[...]. J Clin Invest 2019
Adam Sharp, Ilsa Coleman, Wei Yuan, Cynthia Sprenger, David Dolling, Daniel Nava Rodrigues, Joshua W Russo, Ines Figueiredo, Claudia Bertan, George Seed,[...]. J Clin Invest 2019
22
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, Cristian Lolli, Giorgia Gurioli, Filippo Martignano, Giuseppe Schepisi, Sara Testoni, Emanuela Scarpi, Dino Amadori,[...]. Oncotarget 2016
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, Cristian Lolli, Giorgia Gurioli, Filippo Martignano, Giuseppe Schepisi, Sara Testoni, Emanuela Scarpi, Dino Amadori,[...]. Oncotarget 2016
22
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, Jeffrey Goh, Kristiina Ojamaa, Christopher J Hoimes, Ulka Vaishampayan, Ranaan Berger, Ahmet Sezer, Tuomo Alanko,[...]. J Clin Oncol 2020
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, Jeffrey Goh, Kristiina Ojamaa, Christopher J Hoimes, Ulka Vaishampayan, Ranaan Berger, Ahmet Sezer, Tuomo Alanko,[...]. J Clin Oncol 2020
22
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, Nicola Casiraghi, Michael Sigouros, Gian Marco Franceschini, Francesco Orlando, Tarcisio Fedrizzi, Sheng-Yu Ku, Emma Dann,[...]. J Clin Invest 2020
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, Nicola Casiraghi, Michael Sigouros, Gian Marco Franceschini, Francesco Orlando, Tarcisio Fedrizzi, Sheng-Yu Ku, Emma Dann,[...]. J Clin Invest 2020
22
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.
Stéphane Oudard, Karim Fizazi, Lisa Sengeløv, Gedske Daugaard, Fred Saad, Steinbjørn Hansen, Marie Hjälm-Eriksson, Jacek Jassem, Antoine Thiery-Vuillemin, Orazio Caffo,[...]. J Clin Oncol 2017
Stéphane Oudard, Karim Fizazi, Lisa Sengeløv, Gedske Daugaard, Fred Saad, Steinbjørn Hansen, Marie Hjälm-Eriksson, Jacek Jassem, Antoine Thiery-Vuillemin, Orazio Caffo,[...]. J Clin Oncol 2017
22
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients.
Chiara Foroni, Natasa Zarovni, Laura Bianciardi, Simona Bernardi, Luca Triggiani, Davide Zocco, Marta Venturella, Antonio Chiesi, Francesca Valcamonico, Alfredo Berruti. Biomedicines 2020
Chiara Foroni, Natasa Zarovni, Laura Bianciardi, Simona Bernardi, Luca Triggiani, Davide Zocco, Marta Venturella, Antonio Chiesi, Francesca Valcamonico, Alfredo Berruti. Biomedicines 2020
22
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Melissa R Spears, Alastair W S Ritchie, Christopher C Parker, J Martin Russell, Gerhardt Attard,[...]. Lancet 2016
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Melissa R Spears, Alastair W S Ritchie, Christopher C Parker, J Martin Russell, Gerhardt Attard,[...]. Lancet 2016
22
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer.
Daisuke Obinata, Kenichi Takayama, Satoru Takahashi, Satoshi Inoue. Cancers (Basel) 2017
Daisuke Obinata, Kenichi Takayama, Satoru Takahashi, Satoshi Inoue. Cancers (Basel) 2017
22
Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
22
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
22
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
Mara P Steinkamp, Orla A O'Mahony, Michele Brogley, Haniya Rehman, Elizabeth W Lapensee, Saravana Dhanasekaran, Matthias D Hofer, Rainer Kuefer, Arul Chinnaiyan, Mark A Rubin,[...]. Cancer Res 2009
Mara P Steinkamp, Orla A O'Mahony, Michele Brogley, Haniya Rehman, Elizabeth W Lapensee, Saravana Dhanasekaran, Matthias D Hofer, Rainer Kuefer, Arul Chinnaiyan, Mark A Rubin,[...]. Cancer Res 2009
22
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.
Shihua Sun, Cynthia C T Sprenger, Robert L Vessella, Kathleen Haugk, Kathryn Soriano, Elahe A Mostaghel, Stephanie T Page, Ilsa M Coleman, Holly M Nguyen, Huiying Sun,[...]. J Clin Invest 2010
Shihua Sun, Cynthia C T Sprenger, Robert L Vessella, Kathleen Haugk, Kathryn Soriano, Elahe A Mostaghel, Stephanie T Page, Ilsa M Coleman, Holly M Nguyen, Huiying Sun,[...]. J Clin Invest 2010
22
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, Anne Haegert, Stephane Le Bihan, Robert H Bell, Shawn A Anderson, Brian McConeghy, Robert Shukin, Jenny Bazov,[...]. Clin Cancer Res 2015
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, Anne Haegert, Stephane Le Bihan, Robert H Bell, Shawn A Anderson, Brian McConeghy, Robert Shukin, Jenny Bazov,[...]. Clin Cancer Res 2015
22
Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
22
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.
Pernelle Lavaud, Clément Dumont, Constance Thibault, Laurence Albiges, Giulia Baciarello, Emeline Colomba, Ronan Flippot, Alina Fuerea, Yohann Loriot, Karim Fizazi. Ther Adv Med Oncol 2020
Pernelle Lavaud, Clément Dumont, Constance Thibault, Laurence Albiges, Giulia Baciarello, Emeline Colomba, Ronan Flippot, Alina Fuerea, Yohann Loriot, Karim Fizazi. Ther Adv Med Oncol 2020
50
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.
Heini M L Kallio, Reija Hieta, Leena Latonen, Anniina Brofeldt, Matti Annala, Kati Kivinummi, Teuvo L Tammela, Matti Nykter, William B Isaacs, Hans G Lilja,[...]. Br J Cancer 2018
Heini M L Kallio, Reija Hieta, Leena Latonen, Anniina Brofeldt, Matti Annala, Kati Kivinummi, Teuvo L Tammela, Matti Nykter, William B Isaacs, Hans G Lilja,[...]. Br J Cancer 2018
22
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer.
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, Emanuela Scarpi, Anuradha Jayaram, Nuria Romero-Laorden, David Olmos, Giorgia Gurioli, Cristian Lolli, Maria Isabel Sáez,[...]. Eur J Cancer 2019
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, Emanuela Scarpi, Anuradha Jayaram, Nuria Romero-Laorden, David Olmos, Giorgia Gurioli, Cristian Lolli, Maria Isabel Sáez,[...]. Eur J Cancer 2019
22
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, Primo N Lara, Jeffrey A Jones, Mary Ellen Taplin, Patrick A Burch, Donna Berry, Carol Moinpour, Manish Kohli,[...]. N Engl J Med 2004
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, Primo N Lara, Jeffrey A Jones, Mary Ellen Taplin, Patrick A Burch, Donna Berry, Carol Moinpour, Manish Kohli,[...]. N Engl J Med 2004
22
Biological Evolution of Castration-resistant Prostate Cancer.
Alastair Davies, Vincenza Conteduca, Amina Zoubeidi, Himisha Beltran. Eur Urol Focus 2019
Alastair Davies, Vincenza Conteduca, Amina Zoubeidi, Himisha Beltran. Eur Urol Focus 2019
22
Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer.
Ryon P Graf, Melanie Hullings, Ethan S Barnett, Emily Carbone, Ryan Dittamore, Howard I Scher. Eur Urol 2020
Ryon P Graf, Melanie Hullings, Ethan S Barnett, Emily Carbone, Ryan Dittamore, Howard I Scher. Eur Urol 2020
22
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Tom Whitington, Pieter-Jan van Dam, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey,[...]. Clin Cancer Res 2019
Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Tom Whitington, Pieter-Jan van Dam, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey,[...]. Clin Cancer Res 2019
22
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence.
Isabel Coutinho, Tanya K Day, Wayne D Tilley, Luke A Selth. Endocr Relat Cancer 2016
Isabel Coutinho, Tanya K Day, Wayne D Tilley, Luke A Selth. Endocr Relat Cancer 2016
22
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Pasquale Rescigno, Praful Ravi, Carmel Pezaro, Aurelius Omlin, David Lorente,[...]. Eur Urol 2015
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Pasquale Rescigno, Praful Ravi, Carmel Pezaro, Aurelius Omlin, David Lorente,[...]. Eur Urol 2015
22
Clinical relevance of androgen receptor alterations in prostate cancer.
Emma Jernberg, Anders Bergh, Pernilla Wikström. Endocr Connect 2017
Emma Jernberg, Anders Bergh, Pernilla Wikström. Endocr Connect 2017
22
Genomic correlates of clinical outcome in advanced prostate cancer.
Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia, Ilsa Coleman, Marcin Cieslik, Matteo Benelli, Dan Robinson, Eliezer M Van Allen,[...]. Proc Natl Acad Sci U S A 2019
Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia, Ilsa Coleman, Marcin Cieslik, Matteo Benelli, Dan Robinson, Eliezer M Van Allen,[...]. Proc Natl Acad Sci U S A 2019
22
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
Paymaneh D Malihi, Ryon P Graf, Angel Rodriguez, Naveen Ramesh, Jerry Lee, Ramsay Sutton, Rhett Jiles, Carmen Ruiz Velasco, Emi Sei, Anand Kolatkar,[...]. Clin Cancer Res 2020
Paymaneh D Malihi, Ryon P Graf, Angel Rodriguez, Naveen Ramesh, Jerry Lee, Ramsay Sutton, Rhett Jiles, Carmen Ruiz Velasco, Emi Sei, Anand Kolatkar,[...]. Clin Cancer Res 2020
22
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.
Jane Goodall, Joaquin Mateo, Wei Yuan, Helen Mossop, Nuria Porta, Susana Miranda, Raquel Perez-Lopez, David Dolling, Dan R Robinson, Shahneen Sandhu,[...]. Cancer Discov 2017
Jane Goodall, Joaquin Mateo, Wei Yuan, Helen Mossop, Nuria Porta, Susana Miranda, Raquel Perez-Lopez, David Dolling, Dan R Robinson, Shahneen Sandhu,[...]. Cancer Discov 2017
22
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, Patrizia Procacci, Patrizia Limonta. Int J Oncol 2007
Marina Montagnani Marelli, Roberta M Moretti, Stefania Mai, Patrizia Procacci, Patrizia Limonta. Int J Oncol 2007
11
Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
G Irmer, C Bürger, O Ortmann, K D Schulz, G Emons. J Clin Endocrinol Metab 1994
G Irmer, C Bürger, O Ortmann, K D Schulz, G Emons. J Clin Endocrinol Metab 1994
11
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.
D Dondi, C Festuccia, M Piccolella, M Bologna, M Motta. Oncol Rep 2006
D Dondi, C Festuccia, M Piccolella, M Bologna, M Motta. Oncol Rep 2006
11
Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation.
Carsten Gründker, Andreas R Günthert, Robert P Millar, Günter Emons. J Clin Endocrinol Metab 2002
Carsten Gründker, Andreas R Günthert, Robert P Millar, Günter Emons. J Clin Endocrinol Metab 2002
11
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.
Kathryn E Ware, Mariano A Garcia-Blanco, Andrew J Armstrong, Scott M Dehm. Endocr Relat Cancer 2014
Kathryn E Ware, Mariano A Garcia-Blanco, Andrew J Armstrong, Scott M Dehm. Endocr Relat Cancer 2014
11
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials.
Mohammad Abufaraj, Takehiro Iwata, Shoji Kimura, Anoud Haddad, Hashim Al-Ani, Lana Abusubaih, Marco Moschini, Alberto Briganti, Pierre I Karakiewicz, Shahrokh F Shariat. Eur Urol 2021
Mohammad Abufaraj, Takehiro Iwata, Shoji Kimura, Anoud Haddad, Hashim Al-Ani, Lana Abusubaih, Marco Moschini, Alberto Briganti, Pierre I Karakiewicz, Shahrokh F Shariat. Eur Urol 2021
11
Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.
Zhonglin Cai, Weijie Chen, Jianzhong Zhang, Hongjun Li. Int Urol Nephrol 2018
Zhonglin Cai, Weijie Chen, Jianzhong Zhang, Hongjun Li. Int Urol Nephrol 2018
11
Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs.
Magdolna Kovács, Borbála Vincze, Judit E Horváth, János Seprodi. Peptides 2007
Magdolna Kovács, Borbála Vincze, Judit E Horváth, János Seprodi. Peptides 2007
11
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines.
Yingming Li, Siu Chiu Chan, Lucas J Brand, Tae Hyun Hwang, Kevin A T Silverstein, Scott M Dehm. Cancer Res 2013
Yingming Li, Siu Chiu Chan, Lucas J Brand, Tae Hyun Hwang, Kevin A T Silverstein, Scott M Dehm. Cancer Res 2013
11
Prostate cancer.
Richard J Rebello, Christoph Oing, Karen E Knudsen, Stacy Loeb, David C Johnson, Robert E Reiter, Silke Gillessen, Theodorus Van der Kwast, Robert G Bristow. Nat Rev Dis Primers 2021
Richard J Rebello, Christoph Oing, Karen E Knudsen, Stacy Loeb, David C Johnson, Robert E Reiter, Silke Gillessen, Theodorus Van der Kwast, Robert G Bristow. Nat Rev Dis Primers 2021
11
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
Jinpei Kumagai, Johannes Hofland, Sigrun Erkens-Schulze, Natasja F J Dits, Jacobie Steenbergen, Guido Jenster, Yukio Homma, Frank H de Jong, Wytske M van Weerden. Prostate 2013
Jinpei Kumagai, Johannes Hofland, Sigrun Erkens-Schulze, Natasja F J Dits, Jacobie Steenbergen, Guido Jenster, Yukio Homma, Frank H de Jong, Wytske M van Weerden. Prostate 2013
11
Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
G Srkalovic, L Bokser, S Radulovic, E Korkut, A V Schally. Endocrinology 1990
G Srkalovic, L Bokser, S Radulovic, E Korkut, A V Schally. Endocrinology 1990
11
Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors.
Craig A McArdle, J Franklin, L Green, J N Hislop. J Endocrinol 2002
Craig A McArdle, J Franklin, L Green, J N Hislop. J Endocrinol 2002
11
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.